Prevalence of the prothrombin gene variant 20210 G --> A among patients with myocardial infarction

Cardiovascular Research
V R ArrudaJ M Annichino-Bizzacchi

Abstract

The aim of this study was to determine the prevalence of the prothrombin variant allele 20210A among survivors of myocardial infarction. The prothrombin gene variant has been identified as a novel genetic risk factor for venous thrombosis. However, the risk of developing arterial thrombosis as a result of the presence of this mutated allele is unknown. The G-->A transition at position 20210 of the 3'-untranslated region was determined in 220 survivors of myocardial infarction and in 295 individuals from the general population. The prevalence of heterozygotes for the prothrombin mutated allele was 3% among patients with myocardial infarction and 0.7% in the general population (P = 0.03). No age-related difference in the prevalence of the mutated allele was observed. However, for individuals over 45 years old the prevalence among females was higher than among males (5% vs. 0%). These data suggest that being heterozygote for the allele variant 20210A of the prothrombin gene could be a genetic risk factor for developing myocardial infarction.

Citations

Mar 6, 2007·Journal of Thrombosis and Thrombolysis·Fuat GundogduHuseyin Senocak
Jun 28, 2011·Journal of Molecular Neuroscience : MN·Thierry Paluku They-TheySellama Nadifi
May 20, 1999·The New England Journal of Medicine·R D Rosenberg, W C Aird
Jul 17, 2008·Journal of Translational Medicine·Pierpaolo Di MiccoGiuseppe Castaldo
Jun 5, 2002·Hypertension in Pregnancy : Official Journal of the International Society for the Study of Hypertension in Pregnancy·M G van PampusP H Reitsma
Jan 25, 2002·Current Controlled Trials in Cardiovascular Medicine·Joel G RayDavid EC Cole
Aug 16, 2005·Archives of Medical Research·Antonio de Padua MansurJosé Antonio F Ramires
Jun 24, 2008·American Journal of Obstetrics and Gynecology·Christina M Scifres, George A Macones
Feb 24, 2001·The American Journal of Gastroenterology·L AmitranoA Balzano
May 16, 2008·Thrombosis Research·Yann De Bast, Laurent Dahin
Jan 29, 1999·Hematology/oncology Clinics of North America·E J Neufeld
Jul 10, 2001·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Y MiraJ Aznar
Apr 25, 2000·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·A VayáJ Aznar
Sep 24, 2005·Transplantation·Santiago G MiriukaDavid E C Cole
Oct 25, 2008·The Open Cardiovascular Medicine Journal·Stavroulla XenophontosMarios A Cariolou
Nov 22, 2001·Journal of Applied Physiology·D M Herrington, K P Klein
Mar 19, 2003·Current Opinion in Lipidology·David M Herrington
Dec 3, 1999·Archives of Pathology & Laboratory Medicine·Y J FengG J Tsongalis
Nov 8, 2002·Archives of Pathology & Laboratory Medicine·Elizabeth M Van CottMartin H Prins

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.